Organon (OGN) Equity Average (2020 - 2026)

Organon (OGN) has reported Equity Average for 7 consecutive years, with $827.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Average rose 63.21% year-over-year to $827.5 million; the TTM figure through Mar 2026 stood at $827.5 million (up 63.21% YoY), while the FY2025 annual figure was $612.0 million, up 204.48% from the prior year.
• Equity Average came in at $827.5 million for Q1 2026 at Organon, roughly flat from $829.0 million in the prior quarter.
• The five-year high for Equity Average was $829.0 million in Q4 2025, with the low at -$1.4 billion in Q1 2022.
• Average Equity Average over 5 years is -$147.6 million, with a median of -$11.0 million recorded in 2024.
• Across the five-year window, Equity Average plunged 185.62% in 2022 and soared 4709.09% in 2025, its largest moves.
• Year by year, Equity Average stood at -$979.0 million in 2022, then soared by 66.34% to -$329.5 million in 2023, then surged by 246.43% to $482.5 million in 2024, then surged by 71.81% to $829.0 million in 2025, then dropped by 0.18% to $827.5 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $827.5 million, $829.0 million, and $819.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.